Jiedu Tongluo Tiaogan Prescription Protects Pancreatic β Cell by Targeting NLRP3 Inflammasome via TGR5/cAMP Signaling Pathway
|更新时间:2024-04-30
|
Jiedu Tongluo Tiaogan Prescription Protects Pancreatic β Cell by Targeting NLRP3 Inflammasome via TGR5/cAMP Signaling Pathway
“The latest research has found that Jiedu Tongluo Tiaogan Formula inhibits NLRP3 inflammasome and protects pancreatic beta cells through the TGR5/cAMP signaling pathway.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 11, Pages: 95-103(2024)
Traditional Chinese Medicine Treats Acute Lung Injury by Modulating NLRP3 Inflammasome: A Review
Naoqingtong Decoction Ameliorates Kidney Damage in Spontaneously Hypertensive Rats via NLRP3 Inflammasomes
Role of NLRP3 Inflammasome in IgA Nephropathy and Chinese Medicine Intervention: A Review
Relationship Between NLRP3 Inflammasome and Diabetic Cardiomyopathy and Intervention Effect of Traditional Chinese Medicine: A Review
Related Author
WANG Xijun
MENG Jiaojiao
LIU Lei
FU Yuqi
SUN Hui
HAN Ying
KONG Ling
YAN Guangli
Related Institution
State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine,Chinmedomics Research Center of National Administration of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine
Institute of Integrative Medicine, Shaanxi University of Chinese Medicine
Guangzhou University of Chinese Medicine
Shaanxi Key Laboratory of Integrated Traditional and Western Medicine for Prevention and Treatment of Cardiovascular Diseases, Shaanxi University of Chinese Medicine
Jiujiang Hospital of Traditional Chinese Medicine Affiliated to Jiangxi University of Chinese Medicine